quinta-feira, 8 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 5, 2026

Stock market today: Dow falls more than 1,000 points, S&P 500 and Nasdaq tank as Iran war jitters return with another oil surge

View original at finance.yahoo.com
Stock market today: Dow falls more than 1,000 points, S&P 500 and Nasdaq tank as Iran war jitters return with another oil surge US stock losses accelerated on Thursday as Wall Street failed to build on a rebound session, with conflict in the Middle East holding focus amid a renewed surge in oil prices…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q1 AI revenue of $8.4 billion grew 106% year over year, above forecast

    80% confidence
  • US will offer risk insurance and naval escorts for ships transiting Strait of Hormuz

    80% confidence
  • Goal was to demonstrate alignment with shareholders as CEO

    80% confidence
  • American forces moving toward complete and total control of Iranian airspace

    80% confidence
  • Nvidia has not yet generated any revenue from H200 chips for China

    80% confidence
  • Sticky services inflation warrants caution from the Fed

    80% confidence
  • AI revenue growth is accelerating

    80% confidence
  • Broadcom achieved record Q1 revenue on continued strength in AI semiconductor solutions

    80% confidence
  • US doing very well on the war front

    80% confidence
  • Absolutely believes in Berkshire and inherited company with incredible foundation

    80% confidence
  • Will use all take-home pay to keep buying Berkshire stock

    80% confidence
  • 75% of Cash App customer service handled through automation

    80% confidence
  • Better to automate early than too late; advice to fellow CFOs

    80% confidence
  • Block seeing 40% increase in engineering productivity since September

    80% confidence
  • Fed continuing easing would risk that a 30-50bp inflation overshoot gets entrenched

    80% confidence
  • Tariffs contributed roughly 50 basis points to core PCE inflation, but that's only half the Fed's inflation problem

    80% confidence
  • Strait of Hormuz remains open but increasingly threatened tankers attempting to cross

    80% confidence

Data points we hold from this source

Board of Governors of the Federal Reserve System · target rate3.5-3.75 percent
Board of Governors of the Federal Reserve System · core pce inflation3.0 percent

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com